Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SATTVA S NEELAPU

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1386736304
CMS profile
153290
Location
HOUSTON, TX

General Payments · PY2018–2024

$235,993.20

  • Reported across 207 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$20,834.91

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $9,504.91 9
PFIZER INC. $3,600.00 1
JAZZ PHARMACEUTICALS INC. $3,000.00 1
E.R. Squibb & Sons, L.L.C. $1,730.00 1
GlaxoSmithKline, LLC. $1,600.00 1
ADC Therapeutics America, Inc. $1,400.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $83,837.55 85
PY2019 $57,836.90 72
PY2020 $16,005.62 6
PY2021 $3,464.71 7
PY2022 $15,721.26 7
PY2023 $38,292.25 16
PY2024 $20,834.91 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ADC Therapeutics America, Inc. $1,400.00 10/11/2024 Consulting Fee Undisputed 01/23/2026 1121185970 CMS
E.R. Squibb & Sons, L.L.C. $1,730.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1101490406 CMS
GlaxoSmithKline, LLC. $1,600.00 02/19/2024 Consulting Fee Undisputed 01/23/2026 1116303241 CMS
JAZZ PHARMACEUTICALS INC. $3,000.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1150212569 CMS
Merck Sharp & Dohme LLC $359.00 10/22/2024 Travel and Lodging Undisputed 01/23/2026 1141586488 CMS
Merck Sharp & Dohme LLC $246.48 10/22/2024 Travel and Lodging Undisputed 01/23/2026 1141586490 CMS
Merck Sharp & Dohme LLC $394.47 10/22/2024 Travel and Lodging Undisputed 01/23/2026 1141586516 CMS
Merck Sharp & Dohme LLC $64.66 10/23/2024 Food and Beverage Undisputed 01/23/2026 1141586486 CMS
Merck Sharp & Dohme LLC $246.48 10/23/2024 Travel and Lodging Undisputed 01/23/2026 1141586510 CMS
Merck Sharp & Dohme LLC $59.27 10/23/2024 Food and Beverage Undisputed 01/23/2026 1141586512 CMS
Merck Sharp & Dohme LLC $54.55 10/23/2024 Food and Beverage Undisputed 01/23/2026 1141586514 CMS
Merck Sharp & Dohme LLC $7,930.00 11/06/2024 Consulting Fee Undisputed 01/23/2026 1141678855 CMS
Merck Sharp & Dohme LLC $150.00 11/06/2024 Travel and Lodging Undisputed 01/23/2026 1141678857 CMS
PFIZER INC. $3,600.00 10/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131375744 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.